August 5, 2024

#11 - Dr. Neel Patel: Democratizing Medical Testing & Health Data

Listen and subscribe on your favorite platform

In this episode of our podcast, we are joined by Dr. Neel Patel, a visionary entrepreneur, co-founder, and CEO of ZiO Health. Dr. Patel shares his inspiring journey from practicing medicine to becoming a leading innovator in the healthcare technology sector, driven by a mission to improve patient care through advanced diagnostic solutions.

Bridging Medicine and Technology
Dr. Patel’s journey began in the world of medicine, where he encountered firsthand the inefficiencies and delays in lab testing and patient treatment. Frustrated by these challenges, he decided to transition into entrepreneurship, aiming to bring lab testing directly to the point of care. His clinical insights revealed the critical need for immediate and accurate diagnostic results, leading him to focus on developing a portable therapeutic drug monitoring device.

Finding the Right Co-Founder
Recognizing the technological gaps in his vision, Dr. Patel pursued an MBA and actively networked at events in London and Oxford to find a co-founder with the necessary technical expertise and passion for innovation. His efforts paid off when he met an individual who not only shared his drive but also conducted significant research to develop their device. This partnership was instrumental in assembling a dedicated team that could bring their vision to life.

Navigating Early Challenges
Dr. Patel emphasizes the importance of understanding the entire pathway from pre-seed to Series A funding in the medtech industry. He discusses the unique challenges of securing regulatory approval and reimbursement, which are crucial for the success of any medical device. Early engagement with the FDA and meticulous planning for funding and regulatory milestones were key strategies that helped his startup navigate these hurdles.

Building a Collaborative Culture
In building his team, Dr. Patel focused on hiring individuals who shared his commitment to innovation and collaboration. He believes in empowering his team with the resources and trust they need to excel, fostering a culture of mutual respect and shared goals. This collaborative approach not only drives the company’s progress but also ensures a supportive environment for new team members.

The Road Ahead
Looking to the future, Dr. Patel is excited about the potential applications of their technology beyond therapeutic drug monitoring. He envisions expanding into areas like biomarker detection and water quality testing, ultimately aiming to have their device in every home for comprehensive health monitoring. Additionally, his passion for mentoring and investing in other startups reflects his commitment to fostering innovation across the healthcare industry.

Dr. Patel’s journey from medicine to medtech exemplifies the power of combining clinical insights with technological innovation to create impactful solutions. His dedication to improving patient care and his proactive approach to overcoming challenges offer valuable lessons for aspiring entrepreneurs in the healthcare sector.

About this Guest

Dr. Neel Patel

Dr. Neel Patel is the co founder and CEO of Zio Health, a medtech company based in London, UK. After a career of being a physician, he stated ZiO Health and worked towards a shared goal with his team: bringing hospital-grade lab testing to the point-of-use, enhancing accessibility to molecular testing and optimizing health and sickness prevention. More specifically, they have developed a point-of-care therapeutic drug monitoring device which measures medication concentration levels to improve drug treatment outcomes.

Dr. Patel is also a Partner at HealthTech Investors, an angel syndicate that invests in founders working on the best solutions in improving healthcare.

Explore Other Episodes

#14 – Fabrice Paublant: Cooling the Future with Liquid Ventilation

Fabrice Paublant is the Chief Executive Officer at Orixha.

Orixha, a DeepTech company founded in 2018, emerged from a collaboration between researchers and clinicians at Sherbrooke University, EnvA, and INSERM. Dedicated to revolutionizing critical care, Orixha’s mission is to deliver the transformative benefits of liquid ventilation to patients worldwide. The company’s multidisciplinary team, blending expertise in engineering, pathophysiology, and pharmacology, has developed Vent2Cool—the first liquid ventilator designed for intensive care units. Published in leading scientific journals, their work highlights rapid therapeutic hypothermia and anti-inflammatory benefits, particularly for post-cardiac arrest syndrome and acute respiratory distress. 

Read More »

16 – Sharing the Inside View: Reflections from the USD Discovery District Team

Ryan Oines leads the USD Discovery District as President and CEO, driving economic growth through biotech and life sciences innovation. With over 25 years of experience launching startups and securing capital, he oversees a $314M development plan for 26 buildings, fostering 2,800 jobs. His strategic vision strengthens public-private partnerships, positioning South Dakota as a hub for research and commercialization.

Marc Niamba advances the USD Discovery District’s mission to pioneer life sciences innovation. As a key contributor to GreenLight Bionics, he leverages virtual reality to enhance physical therapy solutions, earning recognition in the 2021 Governor’s Giant Vision Competition. His expertise in computer science and artificial intelligence has enabled him to create internal management and tenant recruitment tools.

Tung Nguyen amplifies the USD Discovery District’s vision of innovation and economic impact. With a background in mechanical engineering and regulatory strategy, he crafts data-driven campaigns to attract biotech tenants and showcase the District’s $23MM funded private public partnership. Nguyen’s strategic storytelling connects academia, industry, and government, driving engagement and growth across South Dakota’s life sciences ecosystem.

Read More »

#15 – Dr. Kristina Harris Jackson: Measuring What Matters

Kristina Harris Jackson is the Director of Research and Education for OmegaQuant Analytics in Sioux Falls, South Dakota. She is also an Assistant Professor in the Department of Internal Medicine at the University of South Dakota Sanford School of Medicine.
Kristina received her PhD in Nutritional Sciences from Pennsylvania State University in 2013 and completed her training to become a Registered Dietitian in 2014. As a graduate student, she studied under Dr. Penny Kris-Etherton, an internationally-recognized expert in fats and nutrition. She worked as a postdoctoral fellow at the University of Colorado-Denver under Dr. John Peters in the area of worksite wellness before returning to the omega-3 field. Kristina joined the family business, OmegaQuant Analytics, as a Research Associate in 2014, with a particular focus on omega-3s in maternal health, helping create the Prenatal DHA test and the Mother’s Milk DHA test. In 2020, she became Assistant Professor in the Department of Internal Medicine at the University of South Dakota Sanford School of Medicine.
Kristina is also the co-founder of Midtown Coffee Radio Hour, a live radio show produced and performed by local artists in Sioux Falls, South Dakota. She lives in Sioux Falls with her husband, two kids, one old dog, and four grandparents.

Read More »

Join our newsletter for regular updates on the podcast, USD Discovery District, and medtech and life science related insights.

By submitting your email to subscribe, you agree to our Privacy Policy.

Proudly Sponsored By